Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$47.40
-1.4%
$47.47
$41.61
$63.33
$97.81B0.3612.77 million shs10.71 million shs
Citigroup Inc. stock logo
C
Citigroup
$93.44
+0.4%
$80.43
$53.51
$93.79
$173.87B1.3414.68 million shs16.59 million shs
Truist Financial Corporation stock logo
TFC
Truist Financial
$44.31
-1.6%
$41.67
$33.56
$49.06
$58.94B0.858.37 million shs13.74 million shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
+1.91%-0.98%+1.73%-2.38%+11.35%
Citigroup Inc. stock logo
C
Citigroup
+3.37%+6.92%+20.32%+47.23%+37.70%
Truist Financial Corporation stock logo
TFC
Truist Financial
+1.66%-1.05%+15.52%+25.60%+4.52%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
4.8944 of 5 stars
3.23.04.24.03.03.31.3
Citigroup Inc. stock logo
C
Citigroup
4.9596 of 5 stars
2.34.02.52.63.22.55.0
Truist Financial Corporation stock logo
TFC
Truist Financial
4.7324 of 5 stars
2.44.03.33.12.91.72.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
2.32
Hold$57.6921.70% Upside
Citigroup Inc. stock logo
C
Citigroup
2.67
Moderate Buy$96.463.24% Upside
Truist Financial Corporation stock logo
TFC
Truist Financial
2.76
Moderate Buy$48.449.33% Upside

Current Analyst Ratings Breakdown

Latest BMY, C, and TFC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/16/2025
Citigroup Inc. stock logo
C
Citigroup
Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
7/16/2025
Citigroup Inc. stock logo
C
Citigroup
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$110.00 ➝ $115.00
7/16/2025
Citigroup Inc. stock logo
C
Citigroup
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$93.00 ➝ $99.00
7/16/2025
Citigroup Inc. stock logo
C
Citigroup
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$95.00 ➝ $100.00
7/16/2025
Citigroup Inc. stock logo
C
Citigroup
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOutperform ➝ Outperform$107.00 ➝ $123.00
7/16/2025
Citigroup Inc. stock logo
C
Citigroup
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$84.00 ➝ $104.00
7/16/2025
Citigroup Inc. stock logo
C
Citigroup
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$85.00 ➝ $95.00
7/16/2025
Citigroup Inc. stock logo
C
Citigroup
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$103.00 ➝ $107.00
7/15/2025
Citigroup Inc. stock logo
C
Citigroup
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$89.00
7/10/2025
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$36.00 ➝ $34.00
7/9/2025
Citigroup Inc. stock logo
C
Citigroup
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$84.00 ➝ $93.00
(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$48.30B2.00$5.81 per share8.16$8.08 per share5.87
Citigroup Inc. stock logo
C
Citigroup
$170.76B1.02$9.02 per share10.36$105.89 per share0.88
Truist Financial Corporation stock logo
TFC
Truist Financial
$24.25B2.39$4.67 per share9.49$43.52 per share1.02
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
-$8.95B$2.6717.757.782.4711.38%87.62%15.98%7/31/2025 (Estimated)
Citigroup Inc. stock logo
C
Citigroup
$12.68B$6.7713.809.890.688.44%7.29%0.57%N/A
Truist Financial Corporation stock logo
TFC
Truist Financial
$4.82B$3.3913.079.741.6915.59%8.96%0.99%7/18/2025 (Estimated)

Latest BMY, C, and TFC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/31/2025Q2 2025
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$1.53N/AN/AN/A$11.32 billionN/A
7/18/2025Q2 2025
Truist Financial Corporation stock logo
TFC
Truist Financial
$0.9340$0.91-$0.0240$0.90$5.04 billion$5.04 billion
7/15/2025Q2 2025
Citigroup Inc. stock logo
C
Citigroup
$1.61$1.96+$0.35$1.96$20.75 billion$21.67 billion
4/24/2025Q1 2025
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$1.50$1.80+$0.30$1.21$10.77 billion$11.20 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$2.485.23%N/A92.88%17 Years
Citigroup Inc. stock logo
C
Citigroup
$2.242.40%N/A33.09%2 Years
Truist Financial Corporation stock logo
TFC
Truist Financial
$2.084.69%N/A61.36%N/A

Latest BMY, C, and TFC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/14/2025
Citigroup Inc. stock logo
C
Citigroup
quarterly$0.602.74%8/4/20258/4/20258/22/2025
6/17/2025
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
quarterly$0.625.25%7/3/20257/3/20258/1/2025
4/30/2025
Truist Financial Corporation stock logo
TFC
Truist Financial
quarterly$0.525.5%5/9/20255/9/20256/2/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
2.65
1.28
1.17
Citigroup Inc. stock logo
C
Citigroup
1.61
0.99
0.98
Truist Financial Corporation stock logo
TFC
Truist Financial
0.55
0.83
0.83

Institutional Ownership

CompanyInstitutional Ownership
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
76.41%
Citigroup Inc. stock logo
C
Citigroup
71.72%
Truist Financial Corporation stock logo
TFC
Truist Financial
71.28%

Insider Ownership

CompanyInsider Ownership
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
0.09%
Citigroup Inc. stock logo
C
Citigroup
0.08%
Truist Financial Corporation stock logo
TFC
Truist Financial
0.17%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
34,1002.04 billion2.03 billionOptionable
Citigroup Inc. stock logo
C
Citigroup
239,0001.87 billion1.87 billionOptionable
Truist Financial Corporation stock logo
TFC
Truist Financial
38,3351.31 billion1.31 billionOptionable

Recent News About These Companies

Truist reports second quarter 2025 results
Truist announces redemption of senior notes due July 2026
Truist Financial (TFC) to Release Earnings on Friday

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Bristol Myers Squibb stock logo

Bristol Myers Squibb NYSE:BMY

$47.40 -0.66 (-1.37%)
Closing price 03:59 PM Eastern
Extended Trading
$47.42 +0.02 (+0.05%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Citigroup stock logo

Citigroup NYSE:C

$93.44 +0.35 (+0.38%)
Closing price 03:59 PM Eastern
Extended Trading
$93.57 +0.13 (+0.14%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Citigroup Inc., a diversified financial service holding company, provides various financial product and services to consumers, corporations, governments, and institutions worldwide. It operates through five segments: Services, Markets, Banking, U.S. Personal Banking, and Wealth. The Services segment includes Treasury and Trade Solutions, which provides cash management, trade, and working capital solutions to multinational corporations, financial institutions, and public sector organizations; and Securities Services, such as cross-border support for clients, local market expertise, post-trade technologies, data solutions, and various securities services solutions. The Markets segment offers sales and trading services for equities, foreign exchange, rates, spread products, and commodities to corporate, institutional, and public sector clients; and market-making services, including asset classes, risk management solutions, financing, prime brokerage, research, securities clearing, and settlement. The banking segment includes investment banking; advisory services related to mergers and acquisitions, divestitures, restructurings, and corporate defense activities; and corporate lending, which includes corporate and commercial banking. The U.S. Personal Banking segment provides co-branded cards and retail banking services. The Wealth segment provides financial services to high-net-worth clients through banking, lending, mortgages, investment, custody, and trust product offerings; and to professional industries, including law firms, consulting groups, accounting, and asset management. The company was founded in 1812 and is headquartered in New York, New York.

Truist Financial stock logo

Truist Financial NYSE:TFC

$44.31 -0.70 (-1.56%)
Closing price 03:59 PM Eastern
Extended Trading
$44.38 +0.07 (+0.16%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Truist Financial Corporation, a financial services company, provides banking and trust services in the Southeastern and Mid-Atlantic United States. The company operates through three segments: Consumer Banking and Wealth, Corporate and Commercial Banking, and Insurance Holdings.Its deposit products include noninterest-bearing checking, interest-bearing checking, savings, and money market deposit accounts, as well as certificates of deposit and individual retirement accounts. The company also provides funding; asset management; automobile lending; credit card lending; consumer finance; home equity and mortgage lending; other direct retail lending; insurance; investment brokerage; mobile/online banking; payment solutions; point-of-sale lending; retail and small business deposit products; small business lending; and wealth management/private banking services. In addition, it offers asset based lending, investment banking and capital market, institutional trust, insurance premium finance, derivatives, commercial lending, international banking, leasing, merchant, commercial deposit and treasury, floor plan, mortgage warehouse lending, real estate lending, and supply chain financing services. Further, the company provides insurance brokerage, retail and wholesale brokerage, securities underwriting and market making, loan syndication, and investment management and advisory services. The company was formerly known as BB&T Corporation and changed its name to Truist Financial Corporation in December 2019. Truist Financial Corporation was founded in 1872 and is headquartered in Charlotte, North Carolina.